Terug
Dagbereik
€ 4,81
€ 5,00
52-Weeksbereik
€ 3,02
€ 22,42
Volume
30.035
50D / 200D Gem.
€ 4,71
/
€ 6,01
Vorige Slotkoers
€ 4,94
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -78,5 | 0,4 |
| P/B | 24,9 | 2,9 |
| ROE % | -46,9 | 3,7 |
| Net Margin % | -28,6 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
Belangrijkste Punten
Debt/Equity of 0,08 — conservative balance sheet
Negative free cash flow of -22,20M
Capital efficient — spends only 8,63% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)105,40%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-46,94%
ROIC-14,86%
Net Margin-28,59%
Op. Margin-19,22%
Veiligheid
Debt / Equity
0,08
Current Ratio1,86
Interest Coverage-7,35
Waardering
P/E Ratio
-78,53
P/B Ratio24,92
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 105,40% | Revenue Growth (3Y) | 168,58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 42,41M | Net Income (TTM) | -12,13M |
| ROE | -46,94% | ROA | -16,34% |
| Gross Margin | 43,38% | Operating Margin | -19,22% |
| Net Margin | -28,59% | Free Cash Flow (TTM) | -22,20M |
| ROIC | -14,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 1,86 |
| Interest Coverage | -7,35 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -78,53 | P/B Ratio | 24,92 |
| P/S Ratio | 22,45 | PEG Ratio | 2,12 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 952,35M | Enterprise Value | 952,06M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 42,41M | 20,65M | 5,88M | 1,46M | 0,0 |
| Net Income | -12,13M | -19,15M | -20,94M | -5,60M | -1,48M |
| EPS (Diluted) | -0,06 | -0,10 | -0,16 | -1,41 | -0,52 |
| Gross Profit | 18,40M | 8,45M | 713.447,0 | 489.594,0 | -18.787,0 |
| Operating Income | -8,15M | -18,98M | -20,67M | -5,68M | -1,41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 74,23M | 42,39M | 25,48M | 6,98M | 428.607,0 |
| Total Liabilities | 36,01M | 28,93M | 11,18M | 9,66M | 287.281,0 |
| Shareholders' Equity | 38,22M | 13,46M | 14,30M | -2,68M | 141.326,0 |
| Total Debt | 2,92M | 18,20M | 8,22M | 8,27M | 145.000,0 |
| Cash & Equivalents | 3,21M | 466.500,0 | 7,03M | 217.177,0 | 405.774,0 |
| Current Assets | 48,80M | 27,42M | 18,38M | 4,10M | 408.065,0 |
| Current Liabilities | 26,24M | 21,33M | 9,27M | 7,77M | 287.281,0 |